JLK applies for U.S. approval for AI stroke diagnosis solution

[Courtesy of JLK]

JLK Inc., a medical artificial intelligence (AI) service provider in South Korea, has applied for U.S. Food and Drug Administration (FDA) approval for its AI stroke diagnosis solution.

The solution, JLK-LVO, is an AI-based solution that detects large vessel occlusion through CT angiography images.

“We plan to complete our FDA applications for five AI stroke solutions within this year,” said JLK Chief Executive Officer Kim Dong-min.